Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat

Go back to Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat
(NASDAQ: KALA) Delayed: 0.82 -0.02 (2.38%)
Previous Close $0.84    52 Week High
Open $0.98    52 Week Low
Day High $0.98    P/E N/A 
Day Low $0.80    EPS
Volume 100,682